EMPRELVIA

Welcome to the Brand page for “EMPRELVIA”, which is offered here for Pharmaceutical products for the treatment of systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and cystic fibrosis;.

Its status is currently believed to be active. Its class is unavailable. “EMPRELVIA” is believed to be currently owned by “CORBUS PHARMACEUTICALS, INC.”

Owner:
CORBUS PHARMACEUTICALS, INC.
Owner Details
Description:
Pharmaceutical products for the treatment of systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and cystic fibrosis;
Categories: PHARMACEUTICAL PRODUCTS TREATMENT